The United States Food and Drug
Administration has authorized the emergency use of an Italian
test for the acute respiratory syndrome caused by the
coronavirus, the makers of the test kit said Friday.
DiaSorin Molecular said the FDA had approved the use of its
Simplexa COVID-19 Direct Kit, which is "able to supply a rapid
and simple response to the detection of the acute respiratory
syndrome caused by Coronavirus 2 (SARS-CoV-2), the virus that
causes COVID-19, directly from the rhino-pharynx swabs".
ALL RIGHTS RESERVED © Copyright ANSA
